495 filings
Page 4 of 25
8-K
an7cgkk57gqv651vsl6
3 May 21
Myriad Genetics Delivers 12% Sequential Revenue Growth in March 2021 Quarter, Company Executes on Strategic Transformation Initiatives
4:05pm
DEFA14A
jp0que0y
15 Apr 21
Additional proxy soliciting materials
7:05am
S-8
lldac8t6i8yp npohhh
16 Mar 21
Registration of securities for employees
4:02pm
10-KT
w79t9l
16 Mar 21
Annual report (with FYE transition)
2:24pm
NT 10-K
yfnsvg
2 Mar 21
Notice of late annual filing
7:05am
8-K
wac3rp y77i9guoivax2
23 Feb 21
Company Continues to Execute Strategic Transformation Plan
4:15pm
8-K
q2v6li zgagdlt
7 Dec 20
Departure of Directors or Certain Officers
5:02pm
8-K
pyhak oszfpy5q
9 Nov 20
Test Volumes Reach 90% of Pre-COVID-19 Level at End of Quarter
8:02am
DEFA14A
msv 3al59
15 Oct 20
Additional proxy soliciting materials
7:20am
8-K
ti9mg4c8v6pebrdro
15 Oct 20
Myriad Genetics Files Fiscal Year 2020 Proxy Statement, Implements Corporate
7:18am
DEFA14A
6pm467
15 Oct 20
Additional proxy soliciting materials
7:05am
8-K
oqxi7d wz9v89
5 Oct 20
Departure of Directors or Certain Officers
7:09am
8-K
w8r5 22potq1i
24 Sep 20
Departure of Directors or Certain Officers
4:15pm
8-K
htedgpt3aae 0zze4s
10 Sep 20
Myriad Genetics Expands Board of Directors with New Member
7:24am
8-K
16nubz0y33cn66 be
14 Aug 20
Myriad Genetics Announces Inducement Awards
4:18pm
S-8
51ym1
14 Aug 20
Registration of securities for employees
12:00am